Currently, lung cancer screening using low-dose computed tomography (LDCT) is recommended for heavy smokers in North America, Europe, and some countries in Asia. Both the NSLT and NELSON trials revealed a significant reduction of lung cancer mortality in the high-risk group. The incidence of lung cancer reported by the NSLT was 645 cases per 100,000 person-years (1060 cancers) in the LDCT group 1 and 8.9 detected cancers per 1000 screened in the NELSON trial. 2 The previous 2 large cohorts enrolled patients with high lung cancer risk, including smoking history and age, but the percentage of the Asian population was less than 5%. Zhang and colleagues 3 demonstrated that the lung cancer detection rate was as high as 2%, surprisingly in both female and nonsmoking employees. Evidence has shown that the incidence of lung cancer among neversmokers is increasing. [4][5][6][7] It is estimated that 10% to 25% of lung cancer occurs in never-smokers, and the prevalence is relatively high in East Asian women. 8 The NSLT and NELSON trials demonstrated the effectiveness of LDCT screening in smokers, but the effectiveness of LDCT screening among never-smokers is unknown. Recently, the TALENT study in Taiwan enrolled more than 10,397 participants who were nonsmokers, mainly female, with at least 1 potential lung cancer risk, including environmental exposure, tuberculosis/chronic obstructive pulmonary disease, cooking, and family history. The lung cancer detection rate in this population was 2.42% (data not published yet). These findings again remind us of that the different risk factors of lung cancer between the Asian and the Western populations. Therefore, the risk prediction model generated from the studies of Western countries may not be suitable to be directly adapted to the Asian population. The necessity and efficacy of LDCT screening in Asian never-smokers should be verified in the future.The second implicating finding is that 96% of detected lung cancer on LDCT presented as ground-glass opacities (GGOs), 3 which was not described in previous studies. Only 9.7% of participants in the NSLT presented with subsolid nodules. 9 The histologic types of lung cancer detected by LDCT in this study were mainly adenocarcinoma (99%) at early stage (95% before stage Ib), more as adenocarcinoma in situ (26%) and minimally invasive adenocarcinoma (37%), less as invasive adenocarcinoma (36%). 3 Based on previous studies, these patients have 5-year disease-free survival rates of 100% if these nonsolid nodules are completely resected. 10 Data suggest that many nonsolid nodules can resolve, although they need to be followed. 9,11 When assessing subsequent LDCT scans, the most important radiologic factor is change or stability of nodules compared with a previous imaging study. 12 Zhang and colleagues 3 did not provide a clear definition of a positive finding and did not regulate the follow-up strategy of the incidentally found GGOs to tell the natural course of the GGOs lesion but only based on principle. The definition of a positive findin...